Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BNR stock hub

Burning Rock Biotech Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BNRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

176.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BNR

In the news

Latest news · BNR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-9.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-5.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BNR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

CNY

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001792267
Company name	Burning Rock Biotech Limited
Country	China
Country code	US
Cusip	12233L107
Employees	674
Employees Change	-112%
Employees Change Percent	-14.25
Enterprise value	$114.2M
Exchange	NASDAQ
Financial currency	CNY
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2020-06-12
Isin	US12233L2060
Last refreshed	2026-05-10
Market cap	$176.8M
Market cap category	Micro-Cap
Price	$16.86
Price currency	USD
Rev Per Employee	114,455.28x
Sector	Healthcare
Sic	8071
Symbol	BNR
Website	https://www.brbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.48%
EV/Sales	1.48x
FCF yield	-2.8%
P/B ratio	2.3x
P/S ratio	2.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.16%
EBITDA Margin	-6.16%
Gross margin	74.67%
Gross Profit	$57.6M
Gross Profit Growth	11.18%
Gross Profit Growth Q	10.23%
Gross Profit Growth3 Y	1.97%
Gross Profit Growth5 Y	5.12%
Net Income	$-7.9M
Net Income Growth Quarters	13%
Net Income Growth Years	3%
Pretax Margin	-9.97%
Profit Margin	-10.26%
Profit Per Employee	$-11,740
ROA	-4.02
Roa5y	-21.73
ROCE	-9.56
ROE	-9.92
Roe5y	-46.23
ROIC	-5.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	627.71%
Cagr3y	-16.92%
Cagr5y	-42.65%
EPS Growth Quarters	13
EPS Growth Years	3
FCF Growth Q	30.4%
OCF Growth Q	20.86%
Revenue Growth	4.6x
Revenue Growth Q	0.23x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.42x
Revenue Growth5 Y	4.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.63
Assets	$117.3M
Cash	$68.7M
Current Assets	$108.6M
Current Liabilities	$36.3M
Debt	$6.2M
Debt Equity	$0.08
Equity	$76.5M
Interest Coverage	-1,828.2
Liabilities	$40.8M
Long Term Assets	$8.7M
Long Term Liabilities	$4.4M
Net Cash	$62.6M
Net Cash By Market Cap	$35.4
Net Cash Growth	-7.6%
Net Debt Equity	$-0.82
Tangible Book Value	$76.5M
Tangible Book Value Per Share	$7.27
WACC	12.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.99
Inventory Turnover	2.29
Net Working Capital	$4M
Quick ratio	2.68
Working Capital	$70.3M
Working Capital Turnover	$0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.27%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	626.72%
200-day SMA	17.04
3Y total return	-42.65%
50-day SMA	19.15
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.79%
All Time High	397.5
All Time High Change	-95.76%
All Time High Date	2021-02-22
All Time Low	2.18
All Time Low Change	673.39%
All Time Low Date	2025-05-05
ATR	1.46
Beta	1.5
Beta1y	3.6
Beta2y	1.93
Ch YTD	-16.33
High	16.86
High52	41.72
High52 Date	2026-01-22
High52ch	-59.59%
Low	16.59
Low52	2.26
Low52 Date	2025-05-14
Low52ch	646.02%
Ma50ch	-11.94%
Premarket Change Percent	0
Premarket Price	$16.58
Price vs 200-day SMA	-1.04%
RSI	40.95
RSI Monthly	47.92
RSI Weekly	45.82
Sharpe ratio	2.08x
Sortino ratio	3.78
Total Return	-3.27%
Tr YTD	-16.33
Tr1m	4.79%
Tr1w	-1.37%
Tr3m	-50.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.8M
Operating margin	-10.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,306,422%
Float Percent	40.83%
Net Borrowing	279,378.9
Shares Insiders	23.83%
Shares Institutions	12.74%
Shares Out	10,546,342
Shares Qo Q	-2.76%
Shares Yo Y	3.27%
Short Ratio	1.41
Short Shares	0.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.9M
Average Volume	26,690.6x
Bv Per Share	7.28
CAPEX	$-750,458
Ch1m	4.79
Ch1w	-1.37
Ch1y	626.7
Ch3m	-50.41
Ch3y	-42.65
Ch5y	-93.79
Ch6m	43
Change	1.69%
Change From Open	0.36
Close	16.58
Days Gap	1.33
Depreciation Amortization	3,179,625.9
Dollar Volume	135,618.5
Earnings Date	2026-06-05
Earnings Time	bmo
EBIT	$-7.8M
EBITDA	$-4.7M
EPS	$-0.74
F Score	4
FCF	$-5M
FCF EV Yield	-4.34x
FCF Per Share	$-0.47
Financing CF	271,646
Fiscal Year End	December
Founded	2,014
Income Tax	$222,464
Investing CF	-627,788
Ipr	2.18
Iprfo	-92.61
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2024-05-15
Last Split Type	Reverse
Last10k Filing Date	2026-04-28
Ma150	20.02
Ma150ch	-15.78%
Ma20	18.83
Ma20ch	-10.44%
Net CF	-5,872,412
Next Earnings Date	2026-06-05
Open	16.8
Optionable	No
Position In Range	100
Post Close	16.86
Postmarket Change Percent	-0.59
Postmarket Price	$16.76
Ppne	10,862,398.5
Pre Close	16.58
Price Date	2026-05-08
Ptbv Ratio	2.31
Relative Volume	0.3x
Revenue	77,142,857x
SBC By Revenue	2.57x
Share Based Comp	1,983,873
Tax By Revenue	0.29x
Tr6m	43%
Volume	8,043.8
Z Score	-4.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BNR pay a dividend?

Capital-return profile for this ticker.

Performance

BNR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BNR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.7%

Float: +40.8% of shares outstanding

Insider ownership

+23.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BNR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.9

Neutral momentum band

Price vs 200-day MA

-1.0%

50/200-day relationship not available

Beta (5Y)

1.50

More volatile than the market

Sharpe ratio

2.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BNR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BNR stock rating?

Burning Rock Biotech Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BNR analysis?

The full report lives at /stocks/BNR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BNR?

The latest report frames BNR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BNR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.